Colonization of an acid resistant Kingella denitrificans in the stomach may contribute to gastric dysbiosis by Helicobacter pylori

J Infect Chemother. 2014 Mar;20(3):169-74. doi: 10.1016/j.jiac.2013.09.007. Epub 2013 Dec 11.

Abstract

In the stomach of a gastric ulcer patient who had been administered an anti-acid, a gram-negative and urease-negative bacillus similar in size to Helicobacter pylori was infected together with H. pylori. According to biochemical test and 16S rRNA gene analysis, the urease-negative bacterium was identified as Kingella denitrificans, a human nasopharyngeal commensal. In contrast to the standard strain of K. denitrificans, the isolate showed catalase activity, did not produce acid from glucose, and exhibited acid tolerance. Acid tolerance of H. pylori was increased by cocultivation with the K. denitrificans isolate, but not with other isolates of K. denitrificans. Disruption of physiological and immunological niche by dysbiotic colonization of bacterium may provide pathological attributes to human stomach. Collectively, a careful administration of anti-acids to the elderly, especially those with atrophic gastritis, is necessary to avoid repression of the gastric barrier to bacteria.

Keywords: Anti-acid administration; Dysbiosis; Gastric barrier to bacteria; Helicobacter pylori; Kingella denitrificans.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Ulcer Agents / adverse effects
  • Anti-Ulcer Agents / therapeutic use
  • Biopsy
  • Carrier State / diagnosis
  • Carrier State / microbiology*
  • Gastric Mucosa / cytology
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / microbiology
  • Helicobacter pylori
  • Humans
  • Hydrogen-Ion Concentration
  • Kingella / isolation & purification*
  • Kingella / physiology
  • Male
  • Microbial Viability
  • Neisseriaceae Infections / diagnosis
  • Neisseriaceae Infections / microbiology*
  • Ranitidine / adverse effects
  • Ranitidine / therapeutic use
  • Stomach Ulcer / drug therapy
  • Stomach Ulcer / microbiology*

Substances

  • Anti-Ulcer Agents
  • Ranitidine